Dietmar Berger
President chez INHIBRX, INC.
Profil
Dietmar P. Berger occupe le poste de Chief Medical Officer & Global Head-Development chez Sanofi. Au cours de sa carrière, il a occupé les postes de chef mondial de la recherche et du développement chez Atara Biotherapeutics, Inc. et de chef du centre de recherche clinique de l'Universittsklinikum Freiburg, de vice-président de l'hématologie et de l'oncologie cliniques chez Genentech, Inc. et de chef du centre de recherche clinique du Scripps Research Institute. Le Dr Berger a obtenu un diplôme d'études supérieures et un doctorat de l'université de Fribourg.
Postes actifs de Dietmar Berger
| Sociétés | Poste | Début |
|---|---|---|
| SANOFI | Directeur Technique/Scientifique/R&D | 01/01/2019 |
| INHIBRX, INC. | President | 30/05/2024 |
Anciens postes connus de Dietmar Berger
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/05/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2018 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Corporate Officer/Principal | - |
Formation de Dietmar Berger
| University of Freiburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| SANOFI | Health Technology |
| INHIBRX, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Health Services |
